Craft

Jacobson Pharma

Stock Price

$0.6

2024-10-29

Market Capitalization

$1.2 B

2024-10-29

Revenue

$1.6 B

FY, 2025

Jacobson Pharma Summary

Company Summary

Overview
Jacobson Pharma is a pharmaceutical company engaged in the research, development, production, sale, and distribution of generics, specialty drugs, and proprietary medicines. Its products cover a range of therapeutic areas such as oncology, cardiovascular, central nervous system, and auto-immune disorders.
Type
Public
Status
Active
Founded
1998
HQ
HK | view all locations
Website
http://www.jacobsonpharma.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Yim Chun Leung, Executive Director

    • Pun Yue Wai, Independent Non-executive Director

      • Young Chun Man, Independent Non-executive Director

        • Wong Chi Kei, Independent Non-executive Director

          LocationsView all

          5 locations detected

          • Kowloon HQ

            Hong Kong

            388 Kwun Tong Rd, Kwun Tong

          • Guangzhou Shi, Guangdong Sheng

            China

            601c, 30 Zhujiang E Rd, Tianhe Qu

          • Singapore

            Singapore

            179 Bishan Street 13

          • Taipei City

            Taiwan

            room 4, 16th floor, No. 189, Section 2, Keelung Rd, Xinyi District

          Jacobson Pharma Financials

          Summary Financials

          Revenue (H1, 2026)
          $766.6M
          Gross profit (H1, 2026)
          $429.6M
          Net income (H1, 2026)
          $142.0M
          Cash (H1, 2026)
          $395.1M
          EBIT (H1, 2026)
          $187.1M
          Enterprise value
          $1.8B

          Footer menu